Psychoendocrine and psychoneuroimmunological mechanisms in the comorbidity of atopic eczema and attention deficit/hyperactivity disorder

Psychoneuroendocrinology

Volumn 38, Issue 1, 2013, Pages 12-23

  Buske Kirschbaum, A ^a   Schmitt, J ^b   Plessow, F ^a   Romanos, M ^c   Weidinger, S ^d,e   Roessner, V ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF KIEL   (Germany)

Author keywords

Atopic eczema; Attention deficit hyperactivity disorder; Genetics; Inflammatory cytokines; Neuroimmunology; Prefrontal cortex; Prenatal programming; Stress

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; NEUROTRANSMITTER; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC TRANSMISSION; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ATOPIC DERMATITIS; ATTENTION DEFICIT DISORDER; BRAIN MATURATION; BRAIN REGION; CHRONIC DISEASE; CLINICAL FEATURE; COMORBIDITY; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRD5 GENE; ENVIRONMENTAL FACTOR; EXPERIMENTAL MODEL; GENE; GENE FUNCTION; HEREDITY; HTR1B GENE; HUMAN; IMMUNOPATHOGENESIS; MENTAL STRESS; NERVE CELL PLASTICITY; NET GENE; NEUROENDOCRINE SYSTEM; NEUROIMMUNOLOGY; PREFRONTAL CORTEX; PRENATAL STRESS; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PSYCHOPHYSIOLOGY; REVIEW; RISK ASSESSMENT; RISK FACTOR; SLC6A3 GENE; SNAP 25 GENE;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN CHEMISTRY; COMORBIDITY; CYTOKINES; DERMATITIS, ATOPIC; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GYRUS CINGULI; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOGLOBULIN E; INFANT; INTERMEDIATE FILAMENT PROTEINS; NEUROIMMUNOMODULATION; PITUITARY-ADRENAL SYSTEM; PREFRONTAL CORTEX; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHONEUROIMMUNOLOGY; RISK; SKIN; T-LYMPHOCYTE SUBSETS;

EID: 84870390955     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2012.09.017     Document Type: Review

References (156)

1. APA Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (Text Revision) 2000, American Psychiatric Association, Washington. 4th ed.
2. Anisman H., Kokkinidis L., Merali Z. Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation. Brain Res. 1996, 731:1-11.
3. Anisman H., Zaharia M.D., Meaney M.J., Merali Z. Do early-life events permanently alter behavioral and hormonal responses to stressors?. Int. J. Dev. Neurosci. 1998, 16:149-164.
4. Arndt J., Smith N., Tausk F. Stress and atopic dermatitis. Curr. Allergy Asthma Rep. 2008, 8:312-317.
5. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nat. Rev. Neurosci. 2009, 10:410-422.
6. Arnsten A.F. Toward a new understanding of attention-deficit hyperactivity disorder pathophysiology: an important role for prefrontal cortex dysfunction. CNS Drugs 2009, 23:33-41.
7. Ball T.M. Cortisol circadian rhythms and stress responses in infants at risk of allergic disease. Neuroimmunomodulation 2006, 13:294-300.
8. Banerjee T.D., Middleton F., Faraone S.V. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007, 96:1269-1274.
9. Banks W.A., Erickson M.A. The blood-brain barrier and immune function and dysfunction. Neurobiol. Dis. 2010, 37:26-32.
10. Barker J.N., Palmer C.N., Zhao Y., Liao H., Hull P.R., Lee S.P., Allen M.H., Meggitt S.J., Reynolds N.J., Trembath R.C., McLean W.H. Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J. Invest. Dermatol. 2007, 127:564-567.
11. Basso A.S., Pinto F.A., Russo M., Britto L.R., de Sa-Rocha L.C., Palermo Neto J. Neural correlates of IgE-mediated food allergy. J. Neuroimmunol. 2003, 140:69-77.
12. Baurecht H., Irvine A.D., Novak N., Illig T., Buhler B., Ring J., Wagenpfeil S., Weidinger S. Toward a major risk factor for atopic eczema: meta analysis of filaggrin polymorphism data. J. Allergy Clin. Immunol. 2007, 120:1406-1412.
13. Bieber T. Atopic dermatitis. N. Engl. J. Med. 2008, 358:1483-1494.
14. Bjorksten B., Clayton T., Ellwood P., Stewart A., Strachan D. Worldwide time trends for symptoms of rhinitis and conjunctivitis: phase III of the International Study of Asthma and Allergies in Childhood. Pediatr. Allergy Immunol. 2008, 19:110-124.
15. Botvinick M.M. Conflict monitoring and decision making: reconciling two perspectives on anterior cingulate function. Cogn. Affect. Behav. Neurosci. 2007, 7:356-366.
16. Brown S.J. Eczema genetics: current state of knowledge and future goals. J. Invest. Dermatol. 2009, 129:543-552.
17. Brown S.M., Henning S., Wellman C.L. Mild, short-term stress alters dendritic morphology in rat medial prefrontal cortex. Cereb. Cortex 2005, 15:1714-1722.
18. Buddenkotte J., Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic disease. Allergy 2010, 65:805-821.
19. Buske-Kirschbaum A., Fischbach S., Rauh W., Hanker J., Hellhammer D. Increased responsiveness of the hypothalamus-pituitary-adrenal (HPA) axis to stress in newborns with atopic disposition. Psychoneuroendocrinology 2004, 29:705-711.
20. Buske-Kirschbaum A., Gierens A., Hollig H., Hellhammer D.H. Stress-induced immunomodulation is altered in patients with atopic dermatitis. J. Neuroimmunol. 2002, 129:161-167.
21. Buske-Kirschbaum A., von Auer K., Krieger S., Weis S., Rauh W., Hellhammer D. Blunted cortisol responses to psychosocial stress in asthmatic children: a general feature of atopic disease?. Psychosom. Med. 2003, 65:806-810.
22. Calcagni E., Elenkov I.J. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. N. Y. Acad. Sci. 2006, 1069:62-76.
23. Capuron L., Pagnoni G., Demetrashvili M., Woolwine B.J., Nemeroff C.B., Berns G.S., Miller A.H. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol. Psychiatry 2005, 58:190-196.
24. Carmi-Levy I., Homey B., Soumelis V. A modular view of cytokine networks in atopic dermatitis. Clin. Rev. Allergy Immunol. 2011, 41:245-253.
25. Carroll C.L., Balkrishnan R., Feldman S.R., Fleischer A.B., Manuel J.C. The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr. Dermatol. 2005, 22:192-199.
26. Castellanos F.X., Elia J., Kruesi M.J., Marsh W.L., Gulotta C.S., Potter W.Z., Ritchie G.F., Hamburger S.D., Rapoport J.L. Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder. Neuropsychopharmacology 1996, 14:125-137.
27. Chamlin S.L. The psychosocial burden of childhood atopic dermatitis. Dermatol. Ther. 2006, 19:104-107.
28. Chen Y.H., Chen H., Liu Y.Y., Lin G.X., Wei L.X., Chen D.L. Function of the hypothalamus-pituitary-adrenal axis in children with attention deficit hyperactivity disorder. Zhongguo Dang Dai Er Ke Za Zhi 2009, 11:992-995.
29. Cherkasova M.V., Hechtman L. Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. Can. J. Psychiatry 2009, 54:651-664.
30. Cheung P.F., Wong C.K., Lam C.W. Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J. Immunol. 2008, 180:5625-5635.
31. Choi E.H., Brown B.E., Crumrine D., Chang S., Man M.Q., Elias P.M., Feingold K.R. Mechanisms by which psychological stress alters cutaneous permeability barrier homeostasis and stratum corneum integrity. J. Invest. Dermatol. 2005, 124:587-595.
32. Coe C.L., Kramer M., Kirschbaum C., Netter P., Fuchs E. Prenatal stress diminishes the cytokine response of leukocytes to endotoxin stimulation in juvenile rhesus monkeys. J. Clin. Endocrinol. Metab. 2002, 87:675-681.
33. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema. Lancet 1998, 351:1225-1232.
34. Coplan J.D., Andrews M.W., Rosenblum L.A., Owens M.J., Friedman S., Gorman J.M., Nemeroff C.B. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:1619-1623.
35. Costa-Pinto F.A., Basso A.S., Britto L.R., Malucelli B.E., Russo M. Avoidance behavior and neural correlates of allergen exposure in a murine model of asthma. Brain Behav. Immun. 2005, 19:52-60.
36. Costa-Pinto F.A., Basso A.S., Russo M. Role of mast cell degranulation in the neural correlates of the immediate allergic reaction in a murine model of asthma. Brain Behav. Immun. 2007, 21:783-790.
37. Cratty M.S., Ward H.E., Johnson E.A., Azzaro A.J., Birkle D.L. Prenatal stress increases corticotropin-releasing factor (CRF) content and release in rat amygdala minces. Brain Res. 1995, 675:297-302.
38. Danckaerts M., Sonuga-Barke E.J., Banaschewski T., Buitelaar J., Döpfner M., Hollis C., Santosh P., Rothenberger A., Sergeant J., Steinhausen H.C., Taylor E.A., Zuddas A., Coghill D. The quality of life of children with attention deficit/hyperactivity disorder: a systematic review. Eur. Child Adolesc. Psychiatry 2010, 19:83-105.
39. De Bellis M.D., Baum A.S., Birmaher B., Keshaven M.S., Eccard C.H., Boring A.M., Jenkins F.J., Ryan N.D. A.E. Bennett Research Award. Developmental traumatology. Part I: Biological stress systems. Biol. Psychiatry 1999, 45:1259-1270.
40. De Bellis M.D., Lefter L., Trickett P.K., Putnam F.W. Urinary catecholamine excretion in sexually abused girls. J. Am. Acad. Child Adolesc. Psychiatry 1994, 33:320-327.
41. de Kloet R., Sibug R.M., Helmerhorst F.M., Schmidt M. Stress, genes and the mechanism of programming the brain for later life. Neurosci. Biobehav. Rev. 2005, 29:271-281.
42. de Weerth C., Buitelaar J. Physiological stress reactivity in human pregnancy-a review. Neurosci. Biobehav. Rev. 2005, 29:295-312.
43. Del Prete G. The concept of type-1 and type-2 helper T cells and their cytokines in humans. Int. Rev. Immunol. 1998, 16:427-455.
44. Di Cesare A., Di Meglio P., Nestle F.O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis?. J. Invest. Dermatol. 2008, 128:2569-2571.
45. Dunn A.J., Wang J., Ando T. Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv. Exp. Med. Biol. 1999, 461:117-127.
46. Durrant D.M., Metzger D.W. Emerging roles of T helper subsets in the pathogenesis of asthma. Immunol. Invest. 2010, 39:526-549.
47. Egliston K.A., McMahon C., Austin M.P. Stress in pregnancy and infant HPA axis function: conceptual and methodological issues relating to the use of salivary cortisol as an outcome measure. Psychoneuroendocrinology 2007, 32:1-13.
48. Eisenberger N.I., Inagaki T.K., Rameson L.T., Mashal M.N., Irwin M.R. An fMRI study of cytokine-induced depressed mood and social pain: the role of sex differences. Neuroimage 2009, 47:881-890.
49. Elia J., Devoto M. ADHD genetics: 2007 update. Curr. Psychiatry Rep. 2007, 9:434-439.
50. Faraone S.V., Doyle A.E., Lasky-Su J., Sklar P.B., D'Angelo E., Gonzalez-Heydrich J., Kratochvil C., Mick E., Klein K., Rezac A.J., Biederman J. Linkage analysis of attention deficit hyperactivity disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2008, 147B:1387-1391.
51. Faraone S.V., Mick E. Molecular genetics of attention deficit hyperactivity disorder. Pediatr. Clin. North Am. 2010, 33:159-180.
52. Flohr C. Dirt, worms and atopic dermatitis. Br. J. Dermatol. 2003, 148:871-877.
53. Freitag C.M., Rohde L.A., Lempp T., Romanos M. Phenotypic and measurement influences on heritability estimates in childhood ADHD. Eur. Child Adolesc. Psychiatry 2010, 19:311-323.
54. Friedel S., Saar K., Sauer S., Dempfle A., Walitza S., Renner T., Romanos M., Freitag C., Seitz C., Palmason H., Scherag A., Windemuth-Kieselbach C., Schimmelmann B.G., Wewetzer C., Meyer J., Warnke A., Lesch K.P., Reinhardt R., Herpertz-Dahlmann B., Linder M., Hinney A., Remschmidt H., Schafer H., Konrad K., Hubner N., Hebebrand J. Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol. Psychiatry 2007, 12:923-933.
55. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
56. Gil K.M., Keefe F.J., Sampson H.A., McCaskill C.C., Rodin J., Crisson J.E. The relation of stress and family environment to atopic dermatitis symptoms in children. J. Psychosom. Res. 1987, 31:673-684.
57. Gizer I.R., Ficks C., Waldman I.D. Candidate gene studies of ADHD: a meta-analytic review. Hum. Genet. 2009, 126:51-90.
58. Goehler L.E. Cytokines in neural signaling to the brain. Cytokines and the Brain 2009, Elsevier, Oxford. C. Phelps, E. Korneva (Eds.).
59. Goto Y., Yang C.R., Otani S. Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders. Biol. Psychiatry 2010, 67:199-207.
60. Grizenko N., Shayan Y.R., Polotskaia A., Ter-Stepanian M., Joober R. Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD. J. Psychiatry Neurosci. 2008, 33:10-16.
61. Gruber R., Laviolette R., Deluca P., Monson E., Cornish K., Carrier J. Short sleep duration is associated with poor performance in IQ measures in healthy school-age children. Sleep Med. 2010, 11:289-294.
62. Gunnar M.R., Vazquez D.M. Low cortisol and a flattening of expected daytime rhythm: potential indices of risk in human development. Dev. Psychopathol. 2001, 13:515-538.
63. Heim C., Newport D.J., Bonsall R., Miller A.H., Nemeroff C.B. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse. Am. J. Psychiatry 2001, 158:575-581.
64. Holloway J.W., Holgate S.T. Genetics of allergic disease. J. Allergy Clin. Immunol. 2010, 125:S81-S94.
65. Hughes T.K., Cadet P., Rady P.L., Tyring S.K., Chin R., Smith E.M. Evidence for the production and action of interleukin-10 in pituitary cells. Cell. Mol. Neurobiol. 1994, 14:59-69.
66. Huizink A.C., Mulder E.J., Buitelaar J.K. Prenatal stress and risk for psychopathology: specific effects or induction of general susceptibility?. Psychol. Bull. 2004, 130:115-142.
67. Hynd G.W., Semrud-Clikeman M., Lorys A.R., Novey E.S., Eliopulos D., Lyytinen H. Corpus callosum morphology in attention deficit-hyperactivity disorder: morphometric analysis of MRI. J. Learn. Disabil. 1991, 24:141-146.
68. Illi S., von Mutius E., Lau S., Nickel R., Gruber C., Niggemann B., Wahn U. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J. Allergy Clin. Immunol. 2004, 113:925-931.
69. Izquierdo A., Wellman C., Holmes A. Brief uncontrollable stress causes dendritic retraction in infralimbic cortex and resistance to fear extinction in mice. J. Neurosci. 2006, 26:5733-5738.
70. King R.M., Wilson G.V. Use of a diary technique to investigate psychosomatic relations in atopic dermatitis. J. Psychosom. Res. 1991, 35:697-706.
71. Lara C., Fayyad J., de Graaf R., Kessler R.C., Aguilar-Gaxiola S., Angermeyer M., Demytteneare K., de Girolamo G., Haro J.M., Jin R., Karam E.G., Lepine J.P., Mora M.E., Ormel J., Posada-Villa J., Sampson N. Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biol. Psychiatry 2009, 65:46-54.
72. Leung D.Y., Bieber T. Atopic dermatitis. Lancet 2003, 361:151-160.
73. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic dermatitis. J. Clin. Invest. 2004, 113:651-657.
74. Lewis-Jones S. Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema. Int. J. Clin. Pract. 2006, 60:984-992.
75. Linneberg A., Hertzum I., Husemoen L.L., Johansen N., Jorgensen T. Association between alcohol consumption and aeroallergen sensitization in Danish adults. Clin. Exp. Allergy 2006, 36:714-721.
76. Linnet K.M., Dalsgaard S., Obel C., Wisborg K., Henriksen T.B., Rodriguez A., Kotimaa A., Moilanen I., Thomsen P.H., Olsen J., Jarvelin M.R. Maternal lifestyle factors in pregnancy risk of attention deficit hyperactivity disorder and associated behaviors: review of the current evidence. Am. J. Psychiatry 2003, 160:1028-1040.
77. Madras B.K., Miller G.M., Fischman A.J. The dopamine transporter and attention-deficit/hyperactivity disorder. Biol. Psychiatry 2005, 57:1397-1409.
78. Magin P., Adams J., Heeding G., Pond D., Smith W. Experience of appearance-related teasing and bullying in skin diseases and their psychological sequelae: results of a qualitative study. Scand. J. Caring Sci. 2008, 22:430-436.
79. Mansouri F.A., Tanaka K., Buckley M.J. Conflict-induced behavioural adjustment: a clue to the executive functions of the prefrontal cortex. Nat. Rev. Neurosci. 2009, 10:141-152.
80. Matthews S.G. Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol. Metab. 2002, 13:373-380.
81. McCrory E., De Brito S.A., Viding E. Research review: the neurobiology and genetics of maltreatment and adversity. J. Child Psychol. Psychiatry 2010, 51:1079-1095.
82. McEwen B.S. Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol. Sci. 1991, 12:141-147.
83. McGeady S.J. Immunocompetence and allergy. Pediatrics 2004, 113:1107-1113.
84. Miller E.K., Cohen J.D. An integrative theory of prefrontal cortex function. Annu. Rev. Neurosci. 2001, 24:167-202.
85. Montgomery A.J., Asselin M.C., Farde L., Grasby P.M. Measurement of methylphenidate-induced change in extrastriatal dopamine concentration using [11C]FLB 457 PET. J. Cereb. Blood Flow Metab. 2007, 27:369-377.
86. Murmu M.S., Salomon S., Biala Y., Weinstock M., Braun K., Bock J. Changes of spine density and dendritic complexity in the prefrontal cortex in offspring of mothers exposed to stress during pregnancy. Eur. J. Neurosci. 2006, 24:1477-1487.
87. Novak N., Bieber T., Leung D.Y. Immune mechanisms leading to atopic dermatitis. J. Allergy Clin. Immunol. 2003, 112:S128-S139.
88. O'Connor K.A., Johnson J.D., Hansen M.K., Wieseler Frank J.L., Maksimova E., Watkins L.R., Maier S.F. Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res. 2003, 991:123-132.
89. O'Connor T.G., Heron J., Golding J., Beveridge M., Glover V. Maternal antenatal anxiety and children's behavioural/emotional problems at 4 years. Report from the Avon Longitudinal Study of Parents and Children. Br. J. Psychiatry 2002, 180:502-508.
90. Ohira H., Fukuyama S., Kimura K., Nomura M., Isowa T., Ichikawa N., Matsunaga M., Shinoda J., Yamada J. Regulation of natural killer cells redistribution by prefrontal cortex during stochastic learning. Neuroimage 2009, 47:897-907.
91. Ong P.Y., Leung D.Y. Immune dysregulation in atopic dermatitis. Curr. Allergy Asthma Rep. 2006, 6:384-389.
92. Oswald L.M., Zandi P., Nestadt g., Potash G., Kalaydijan A.E., Wand G.S. Relationship between cortisol responses to stress and personality. Neuropsychopharmacology 2006, 31:1583-1591.
93. Palermo-Neto J., Guimaraes R.K. Pavlovian conditioning of lung anaphylactic response in rats. Life Sci. 2000, 68:611-623.
94. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., O'Regan G.M., Watson R.M., Cecil J.E., Bale S.J., Compton J.G., DiGiovanna J.J., Fleckman P., Lewis-Jones S., Arseculeratne G., Sergeant A., Munro C.S., El Houate B., McElreavey K., Halkjaer L.B., Bisgaard H., Mukhopadhyay S., McLean W.H. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat. Genet. 2006, 38:441-446.
95. Pascual R., Zamora-Leon S.P. Effects of neonatal maternal deprivation and postweaning environmental complexity on dendritic morphology of prefrontal pyramidal neurons in the rat. Acta Neurobiol. Exp. 2007, 67:471-479.
96. Pauli-Pott U., Darui A., Beckmann D. Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament. Psychother. Psychosom. 1999, 68:39-45.
97. Picardi A., Abeni D. Stressful life events and skin diseases: disentangling evidence for myth. Psychother. Psychosom. 2001, 70:118-136.
98. Pietinalho A., Pelkonen A., Rytila P. Linkage between smoking and asthma. Allergy 2009, 64:1722-1727.
99. Polanczyk G., de Lima M.S., Horta B.L., Biederman J., Rohde L.A. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am. J. Psychiatry 2007, 164:942-948.
100. Prescott S.L., Macaubas C., Smallacombe T., Holt B.J., Sly P.D., Holt P.G. Development of allergen-specific T-cell memory in atopic and normal children. Lancet 1999, 353:196-200.
101. Pruessner J.C., Champagne F., Meaney M.J., Dagher A. Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care: a positron emission tomography study using [11C]raclopride. J. Neurosci. 2004, 24:2825-2831.
102. Raison C.L., Capuron L., Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006, 27:24-31.
103. Reif A., Jacob C.P., Rujescu D., Herterich S., Lang S., Gutknecht L., Baehne C.G., Strobel A., Freitag C.M., Giegling I., Romanos M., Hartmann A., Rosler M., Renner T.J., Fallgatter A.J., Retz W., Ehlis A.C., Lesch K.P. Influence of functional variant of neuronal nitric oxide synthase on impulsive behaviors in humans. Arch. Gen. Psychiatry 2009, 66:41-50.
104. Reimherr F.W., Wender P.H., Ebert M.H., Wood D.R. Cerebrospinal fluid homovanillic acid and 5-hydroxy-indoleacetic acid in adults with attention deficit disorder, residual type. Psychiatry Res. 1984, 11:71-78.
105. Rivest S. How circulating cytokines trigger the neural circuits that control the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2001, 26:761-788.
106. Rodriguez A., Baurecht H., Herberich E., Wagenpfeil S., Brown S.J., Cordell H.J., Irvine A.D., Weidinger S. Meta-analysis of filaggrin polymorphisms in eczema and atham: robust risk factors in atopic diseases. J. Allergy Clin. Immunol. 2009, 123:1361-1370.
107. Rodriguez A., Bohlin G. Are maternal smoking and stress during pregnancy related to ADHD symptoms in children?. J. Child Psychol. Psychiatry 2005, 46:246-254.
108. Roessner V., Becker A., Rothenberger A., Rohde L.A., Banaschewski T. A cross-cultural comparison between samples of Brazilian and German children with ADHD/HD using the Child Behavior Checklist. Eur. Arch. Psychiatry Clin. Neurosci. 2007, 257:352-359.
109. Roessner V., Rothenberger A. Neurochemie der ADHS. Handbuch ADHS 2010, 76-91. Kohlhammer, Stuttgart. H.C. Steinhausen, A. Rothenberger, M. Döpfner (Eds.).
110. Roll A., Cozzio A., Fischer B., Schmid-Grendelmeier P. Microbial colonization and atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 2004, 4:373-378.
111. Romanos M., Freitag C., Jacob C., Craig D.W., Dempfle A., Nguyen T.T., Halperin R., Walitza S., Renner T.J., Seitz C., Romanos J., Palmason H., Reif A., Heine M., Windemuth-Kieselbach C., Vogler C., Sigmund J., Warnke A., Schafer H., Meyer J., Stephan D.A., Lesch K.P. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol. Psychiatry 2008, 13:522-530.
112. Romanos M., Gerlach M., Warnke A., Schmitt J. Association of attention-deficit/hyperactivity disorder and atopic eczema modified by sleep disturbance in a large population-based sample. J. Epidemiol. Community Health 2010, 64:269-273.
113. Rosenkranz M.A., Busse W.W., Johnstone T., Swenson C.A., Crisafi G.M., Jackson M.M., Bosch J.A., Sheridan J.F., Davidson R.J. Neural circuitry underlying the interaction between emotion and asthma symptom exacerbation. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:13319-13324.
114. Rosner B. Fundamentals of Biostatistics 2000, Duxbury, Pacific Grove, CA. 5th ed.
115. Sanchez M.M. The impact of early adverse care on HPA axis development: nonhuman primate models. Horm. Behav. 2006, 50:623-631.
116. Sanchez M.M., Ladd C.O., Plotsky P.M. Early adverse experience as a developmental risk factor for later psychopathology: evidence from rodent and primate models. Dev. Psychopathol. 2001, 13:419-449.
117. Schlotz W., Phillips D.I. Fetal origins of mental health: evidence and mechanisms. Brain Behav. Immun. 2009, 23:905-916.
118. Schmid-Ott G., Jaeger B., Meyer S., Stephan E., Kapp A., Werfel T. Different expression of cytokine and membrane molecules by circulating lymphocytes on mental stress in patients with atopic dermatitis in comparison with healthy controls. J. Allergy Clin. Immunol. 2001, 108:455-462.
119. Schmitt J., Buske-Kirschbaum A., Roessner V. Is atopic disease a risk factor for attention-deficit/hyperactivity disorder? A systematic review. Allergy 2010, 65:1506-1524.
120. Schmitt J., Romanos M., Pfennig A., Leopold K., Meurer M. Psychiatric comorbidity in adult eczema. Br. J. Dermatol. 2009, 161:878-883.
121. Schmitt J., Romanos M., Schmitt N.M., Meurer M., Kirch W. Atopic eczema and attention-deficit/hyperactivity disorder in a population-based sample of children and adolescents. J. Am. Med. Assoc. 2009, 301:724-726.
122. Schmitt J., Schmitt N.M., Kirch W., Meurer M. Outpatient care and medical treatment of children and adults with atopic eczema. J. Dtsch. Dermatol. Ges. 2009, 7:345-351.
123. Schulkin J., Gold P.W., McEwen B.S. Induction of corticotropin-releasing hormone gene expression by glucocorticoids: implication for understanding the states of fear and anxiety and allostatic load. Psychoneuroendocrinology 1998, 23:219-243.
124. Shamssain M. Trends in the prevalence and severity of asthma, rhinitis and atopic eczema in 6- to 7- and 13- to 14-yr-old children from the north-east of England. Pediatr. Allergy Immunol. 2007, 18:149-153.
125. Shaw P., Lerch J., Greenstein D., Sharp W., Clasen L., Evans A., Giedd J., Castellanos F.X., Rapoport J. Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry 2006, 63:540-549.
126. Shaywitz B.A., Cohen D.J., Bowers M.B. CSF monoamine metabolites in children with minimal brain dysfunction: evidence for alteration of brain dopamine. A preliminary report. J. Pediatr. 1977, 90:67-71.
127. Shenefelt P.D. Biofeedback, cognitive-behavioral methods, and hypnosis in dermatology: it is all in your mind?. Dermatol. Ther. 2003, 16:114-122.
128. Shetty T., Chase T.N. Central monoamines and hyperkinase of childhood. Neurology 1976, 26:1000-1002.
129. Shin D.W., Lee S.H. Blunted hypothalamo-pituitary-adrenal axis reactivity is associated with the poor intelligence performance in children with attention-deficit/hyperactivity disorder. Neuropediatrics 2007, 38:298-303.
130. Spencer T.J., Biederman J., Mick E. Attention-deficit/hyperactivity disorder: diagnosis, lifespan, comorbidities, and neurobiology. J. Pediatr. Psychol. 2007, 32:631-642.
131. Sprafkin J., Gadow K.D., Weiss M.D., Schneider J., Nolan E.E. Psychiatric comorbidity in ADHD symptom subtypes in clinic and community adults. J. Atten. Disord. 2007, 11:114-124.
132. Stefano G.B., Prevot V., Beauvillain J.C., Hughes T.K. Interleukin-10 stimulation of corticotrophin releasing factor median eminence in rats: evidence for dependence upon nitric oxide production. Neurosci. Lett. 1998, 256:167-170.
133. Steinhausen H.C. The heterogeneity of causes and courses of attention-deficit/hyperactivity disorder. Acta Psychiatr. Scand. 2009, 120:392-399.
134. Su J.C., Kemp A.S., Varigos G.A., Nolan T.M. Atopic eczema: its impact on the family and financial cost. Arch. Dis. Child. 1997, 76:159-162.
135. Thayer J.F., Sternberg E.M. Neural aspects of immunomodulation: focus on the vagus nerve. Brain Behav. Immun. 2010, 24:1223-1228.
136. Thomsen S.F., Kyvik K.O., Backer V. Etiological relationships in atopy: a review of twin studies. Twin Res. Hum. Genet. 2008, 11:1112-1120.
137. Tonelli L.H., Katz M., Kovacsics C.E., Gould T.D., Joppy B., Hoshino A., Hoffman G., Komarow H., Postolache T.T. Allergic rhinitis induces anxiety-like behavior and altered social interaction in rodents. Brain Behav. Immun. 2009, 23:784-793.
138. Valera E.M., Faraone S.V., Murray K.E., Seidman L.J. Meta-analysis of structural imaging findings in attention-deficit/hyperactivity disorder. Biol. Psychiatry 2007, 61:1361-1369.
139. Van Goozen S.H.M., Matthys W., Cohen-Hettenis P.T., Buitelaar J.K., Van Engeland H. Hypothalamus-pituitary-adrenal axis and autonomic nervous system activity in disruptive children and matched controls. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39:1438-1445.
140. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat. Rev. Immunol. 2008, 8:169-182.
141. Verne G.M., Himes N.C., Robinson M.E., Gopinath K.S., Briggs R.W., Crosson B. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003, 103:99-110.
142. von Hertzen L.C. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J. Allergy Clin. Immunol. 2002, 109:923-928.
143. Wahn U., von Mutius E. Childhood risk factors for atopy and the importance of early intervention. J. Allergy Clin. Immunol. 2001, 107:567-574.
144. Wegmann T.G., Lin H., Guilbert L., Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon?. Immunol. Today 1993, 14:353-356.
145. Weidinger S., Kramer M., Dunemann L., Mohrenschlager M., Ring J., Behrendt H. Body burden of mercury is associated with acute atopic aczema and total IgE in children from southern Germany. J. Allergy Clin. Immunol. 2004, 114:457-459.
146. Weidinger S., O'Sullivan M., Illig T., Baurecht H., Depner M., Rodriguez A., Ruether A., Klopp N., Vogelberg C., Weiland S.K., McLean W.H., von Mutius E., Irvine A.D., Kabesch M. Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J. Allergy Clin. Immunol. 2008, 121:1203-1209.
147. Weinmann S., Kamtsiuris P., Henke K.D., Wickman M., Jenner A., Wahn U. The costs of atopy and asthma in children: assessment of direct costs and their determinants in a birth cohort. Pediatr. Allergy Immunol. 2003, 14:18-26.
148. Werfel T. The role of leukocytes, keratinocytes and allergen-specific IgE in the development of atopic dermatitis. J. Invest. Dermatol. 2009, 129:1878-1891.
149. WHO Multiaxial Classification of Child and Adolescent Psychiatric Disorders: The ICD-10 Classification of Mental and Behavioural Disorders in Children and Adolescents 1996, Cambridge University Press, Cambridge.
150. Willcutt E.G., Doyle A.E., Nigg J.T., Faraone S.V., Pennington B.F. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol. Psychiatry 2005, 57:1336-1346.
151. Williams H.C. Clinical practice. Atopic dermatitis. N. Engl. J. Med. 2005, 352:2314-2324.
152. Wittkowski A., Richards H.L., Griffiths C.E., Main C.J. The impact of psychological and clinical factors on quality of life in individuals with atopic dermatitis. J. Psychosom. Res. 2004, 57:195-200.
153. Yarlagadda A., Alfson E., Clayton A.H. The blood brain barrier and the role of cytokines in neuropsychiatry. Psychiatry (Edgmont) 2009, 6:18-22.
154. Yukawa K., Kishino M., Goda M., Liang X.M., Kimura A., Tanaka T., Bai T., Owada-Makrabe K., Tsubota Y., Ueyama T., Ichinose M., Takeda K.1, Akira S. STAT6 deficiency inhibits tubulointerstitial fibrosis in obstructive nephropathy. Int. J. Mol. Med. 2005, 15:225-230.
155. Zalcman S., Green-Johnson J.M., Murray L., Nance D.M., Dyck D., Anisman H., Greenberg A.H. Cytokine-specific central monoamine alterations induced by interleukin-1,-2 and-6. Brain Res. 1994, 643:40-49.
156. Zimmer L. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD. Neuropharmacology 2009, 57:601-607.